LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
 7.66 770.25 1037 1090 0.9514 0.8106
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 10.06 770.25 1171 1218 0.9610 0.8834
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 10.06 770.25 1155 1218 0.9479 0.8446
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 12.28 770.25 1351 1358 0.9948 0.9872
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 12.28 770.25 1276 1358 0.9395 0.8532
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 14.50 770.25 1485 1497 0.9918 0.9829
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 14.50 770.25 1436 1497 0.9591 0.9148
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 16.73 770.25 1637 1664 0.9835 0.9703
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 16.73 770.25 1619 1664 0.9727 0.9508
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 18.95 770.25 1756 1832 0.9583 0.9329
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 18.95 770.25 1755 1832 0.9577 0.9321
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 21.17 770.25 1881 2008 0.9366 0.9074
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 21.17 770.25 1912 2008 0.9520 0.9301
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 23.39 770.25 2063 2244 0.9191 0.8936
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 23.39 770.25 2103 2244 0.9370 0.9174
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 25.62 770.25 2362 2514 0.9392 0.9279
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 25.62 770.25 2309 2514 0.9181 0.9024
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 27.84 770.25 2677 2833 0.9446 0.9403
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 27.84 770.25 2512 2833 0.8864 0.8757
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 30.06 770.25 2931 3106 0.9436 0.9431
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 30.06 770.25 2770 3106 0.8918 0.8893
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 32.28 770.25 3105 3392 0.9152 0.9188
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 32.28 770.25 3055 3392 0.9004 0.9043
MN20160304_L02
D18
MCF 10A-H2B-mCherry Trametinib
0.00066667
 34.50 770.25 3439 3712 0.9265 0.9338
MN20160304_L02
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 34.50 770.25 3323 3712 0.8952 0.9048
MN20160304_L02
D18